Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20260711017Phase 2Not yet recruiting
A Phase 2 trial of triamcinolone in severe cutaneous adverse reactions (SCAR), sponsored by Mahidol University. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20260711017.